Fasting and 2-Hour Postchallenge Serum Glucose Measures and Risk of Incident Cardiovascular Events in the Elderly
Nicholas L. Smith, Joshua I. Barzilay, Douglas Shaffer et al. · Archives of Internal Medicine · 2002
BACKGROUND: The contributions of fasting and 2-hour postchallenge glucose level to cardiovascular events remain ill-defined, especially for nondiabetic adults. This study examined the relative predictive power of fasting and 2-hour glucose level on cardiovascular event risk. METHODS: A total of 4014 community-dwelling adults 65 years or older who participated in the baseline visit of the Cardiovascular Health Study and who were without treated diabetes or previous myocardial infarction or stroke were eligible for analyses. Participants with treated diabetes at baseline were excluded. Incident myocardial infarction or stroke, or coronary death, was the outcome of interest. Age-, sex-, and race-adjusted proportional hazards regression models described individual and joint associations between baseline measures of fasting and 2-hour postchallenge glucose level and event risk. RESULTS: There were 764 incident cardiovascular events during 8.5 years of follow-up. Fasting glucose level of 115 mg/dL (6.4 mmol/L) or more was associated with an increased cardiovascular risk (hazard ratio [HR], 1.66 [95% confidence interval (CI), 1.39-1.98]) in adjusted analyses compared with fasting glucose level less than 115 mg/dL. Two-hour glucose level was associated with a linear risk (HR, 1.02 [95% CI, 1.00-1.04] per 10 mg/dL [0.6 mmol/L]) that included an additional increase in risk for 2-hour glucose level of 154 mg/dL (8.5 mmol/L) or more (HR, 1.29 [95% CI, 1.04-1.59]) in adjusted analyses. In joint fasting and 2-hour glucose models, only 2-hour glucose level remained predictive of event risk. CONCLUSIONS: Two-hour glucose level was better than fasting glucose level alone at identifying older adults at increased risk of major incident cardiovascular events.
Cited by 152 works. doi:10.1001/archinte.162.2.209
Authors
- Nicholas L. Smith
- Joshua I. Barzilay
- Douglas Shaffer
- Peter J. Savage
- Susan R. Heckbert
- Lewis H. Kuller
- Richard A. Kronmal
- Helaine E. Resnick
- Bruce M. Psaty
References
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
- The cardiovascular health study: Design and rationale
- Surveillance and ascertainment of cardiovascular events
- Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria
- Recruitment of adults 65 years and older as participants in the cardiovascular health study
- Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.
- High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
- Glucose Tolerance and Cardiovascular Mortality
- Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study